Baker Bros. Advisors as of Sept. 30, 2011
Portfolio Holdings for Baker Bros. Advisors
Baker Bros. Advisors holds 46 positions in its portfolio as reported in the September 2011 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| GTx | 5.2 | $9.2M | 2.7M | 3.35 | |
| Trimeris | 5.0 | $8.8M | 3.5M | 2.52 | |
| Medivation | 4.7 | $8.2M | 483k | 16.98 | |
| 41 Viropharma | 4.7 | $8.1M | 1.1M | 7.41 | |
| 23 Halozyme Therapeutics | 4.6 | $8.0M | 2.9M | 2.73 | |
| 32 Pharmasset | 4.1 | $7.2M | 4.1M | 1.76 | |
| Exelixis (EXEL) | 4.0 | $7.0M | 1.3M | 5.46 | |
| Micromet | 4.0 | $7.0M | 3.5M | 1.98 | |
| 10 Auxilium | 3.9 | $6.8M | 6.5M | 1.06 | |
| Aegerion Pharmaceuticals | 3.5 | $6.1M | 485k | 12.67 | |
| 43 Ym Biosciences | 3.5 | $6.0M | 8.6M | 0.70 | |
| ACADIA Pharmaceuticals (ACAD) | 3.2 | $5.7M | 5.2M | 1.08 | |
| 12 Biocryst Pharmaceuticals | 3.1 | $5.3M | 5.6M | 0.96 | |
| Threshold Pharma | 3.0 | $5.3M | 3.7M | 1.44 | |
| Onyx Pharmaceuticals | 2.9 | $5.1M | 170k | 30.01 | |
| D Tranzyme | 2.9 | $5.0M | 1.9M | 2.64 | |
| 26 Incyte | 2.8 | $4.8M | 1.1M | 4.33 | |
| Chelsea Therapeutics International | 2.3 | $4.1M | 1.1M | 3.64 | |
| 8 Ardea Biosciences | 2.2 | $3.9M | 6.0M | 0.65 | |
| Alere Inc note 3.000% 5/1 | 2.2 | $3.9M | 4.5M | 0.87 | |
| Anthera Pharmaceuticals | 2.2 | $3.9M | 812k | 4.77 | |
| ZIOPHARM Oncology | 2.1 | $3.7M | 850k | 4.41 | |
| 18 Dendreon | 2.0 | $3.5M | 2.6M | 1.35 | |
| Amicus Therapeutics (FOLD) | 2.0 | $3.5M | 902k | 3.84 | |
| 31 Pharmacyclics | 1.8 | $3.2M | 7.0M | 0.45 | |
| Anacor Pharmaceuticals | 1.8 | $3.1M | 539k | 5.70 | |
| 46 Biomarin Pharmaceuticals Notes 1.875% 4/23/2017 conv bonds | 1.8 | $3.1M | 7.9M | 0.39 | |
| Idenix Pharmaceuticals | 1.6 | $2.9M | 573k | 4.99 | |
| 21 Genomic Health | 1.6 | $2.8M | 7.9M | 0.36 | |
| Derma Sciences | 1.5 | $2.6M | 340k | 7.79 | |
| BioDelivery Sciences International | 1.5 | $2.6M | 2.4M | 1.09 | |
| 36 Seattle Genetics | 1.2 | $2.2M | 2.1M | 1.06 | |
| Raptor Pharmaceutical | 1.2 | $2.0M | 452k | 4.51 | |
| 2 Adolor | 1.1 | $1.9M | 6.9M | 0.28 | |
| Salix Pharmaceuticals | 0.9 | $1.5M | 52k | 29.61 | |
| AVANIR Pharmaceuticals | 0.8 | $1.4M | 500k | 2.86 | |
| 9 Ariad Pharmaceuticals | 0.7 | $1.2M | 1.3M | 0.96 | |
| Ligand Pharmaceuticals | 0.6 | $1.0M | 73k | 13.68 | |
| Rigel Pharmaceuticals (RIGL) | 0.5 | $834k | 113k | 7.36 | |
| 14 Biomarin | 0.4 | $752k | 337k | 2.23 | |
| Xoma | 0.4 | $701k | 400k | 1.75 | |
| Idera Pharmaceuticals | 0.2 | $340k | 288k | 1.18 | |
| Cumberland Pharmaceuticals (CPIX) | 0.1 | $132k | 24k | 5.59 | |
| Cyclacel Pharmaceuticals Inc pfd conv ex 6% (CYCCP) | 0.0 | $63k | 21k | 3.00 | |
| Aradigm Corporation (ARDM) | 0.0 | $15k | 100k | 0.15 | |
| VIA Pharmaceuticals (VIAP) | 0.0 | $2.1k | 103k | 0.02 |
